iTeos Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
iTeos Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q2 2024.
  • iTeos Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending June 30, 2024 was $43M, a 9.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $43M +$3.84M +9.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $42M +$2.78M +7.09% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $40.9M +$1.73M +4.41% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $39.9M -$950K -2.32% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $39.2M -$3.33M -7.83% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $39.2M -$100K -0.25% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $39.2M +$22.2M +131% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $40.9M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $42.5M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $39.3M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $17M +$17M Dec 31, 2021 10-K 2023-03-15
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.